However, some people may rarely have side effects like redness, itching at the injection spot, or mild diarrhoea
In this genus, the relative abundance of the vehicle-treated group transitioned from WD to LD was significantly higher than both the lean and obese control groups
The two share the same three peptides at identical doses when inflammation is not a key issue to resolve, KLOW can be switched out for GLOW without regression during a 12-week protocol
A clinically studied GLP-1 pathway treatment for appetite control and metabolic health
Technology appraisal guidance [TA1026]
The side effects we see in clinic are generally mild: transient injection site reaction, occasional mild nausea if starting at too high a dose, infrequent headache or lightheadedness in the first week